← Evidence map

ArticleFrontiers in pharmacology2025

Efficacy and safety of vunakizumab in moderate-to-severe plaque psoriasis patients with different body mass index: a

Xin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2025
2026
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 41567644